Skip to main content
. 2020 Apr 20;103(2):176–182. doi: 10.1093/biolre/ioaa052

Figure 2.

Figure 2

Modulating sAC inhibitors to discover a preclinical candidate. Molecular property optimization directed toward preclinical candidate selection; final candidate (dark blue) is the analog that best balances overall desirable properties versus ligand-associated liabilities.